Jayne Conroy, Named Shareholder of Simmons Hanly Conroy

Jayne Conroy, Esquire

Trial Attorney and Pharmaceutical Litigation Expert
  • Mesothelioma and Asbestos
  • Pharmaceutical Litigation
  • Bachelor of Arts, Dartmouth College
  • Juris Doctor, New England School of Law
  • Elected as member of the American Law Institute in 2019
  • Inducted into the National Trial Lawyers Association’s “Trial Lawyer Hall of Fame” in 2019

Jayne Conroy has more than three decades of experience as a skilled strategist, trial lawyer and negotiator. She is a frequent speaker and expert panelist at national litigation conferences. In 2019, she was one of 68 inductees into the American Law Institute, which limits its active membership to 3,000 prominent judges, lawyers and law professors.

Her practice currently focuses on complex civil cases. She has helped secure landmark settlements and verdicts on behalf of individuals and families harmed by corporate wrongdoing, including a $1 billion verdict against Johnson & Johnson subsidiary DePuy Orthopaedics over its Pinnacle metal-on-metal hip implant and an $894 million settlement of Bextra and Celebrex cases against Pfizer.

In addition to serving on the Plaintiff’s Executive Committee for the federal Pinnacle hip implant litigation, Conroy has been appointed by courts to serve in leadership roles in more than a dozen other high-profile multidistrict litigations involving products such as Actos, Lipitor, Zoloft, Propecia (finasteride), pelvic repair systems, gadolinium-based contrast agents, Bextra and Celebrex, and Yazmin and Yaz (drospirenone).

Bar and Court Admissions

Additional Acknowledgements

Who Am I Calling?

Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.

Drugwatch's sponsors support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(888) 645-1617